Researchers from the Edith Collins Centre and the Matilda Centre for Mental Health and Substance Use are interested to hear from mental health clinicians, alcohol and other drug (AOD) clinicians, and people with lived experience of a mental illness or mental disorder (consumers) about their knowledge, beliefs, and motivations behind interest (or disinterest) in psychedelic-assisted therapy from a mental health clinician and lived experience perspective.
If you are a mental health or AOD clinician, or someone who has lived experience of mental illness or mental disorder, we invite you to complete a 20-minute online survey to help us understand what you think of psychedelic-assisted therapy.
The study is being conducted by the Edith Collins Centre at the Royal Prince Alfred Hospital. The research team is being led by Professor Kirsten Morley.
Taking part in this research study is voluntary. You may choose not to take part at any time. If you decide not to take part in this research, your decision will not affect your relationship with members of the research team, the University of Sydney, nor the Edith Collins Centre or Matilda Centre.
You may be eligible to participate in this study if you:
If you have questions about the research and would like to speak to the Chief Investigator please contact:
Telephone: 02 9515 7611
Professor Kirsten Morley, Dr Eva Louie, Dr Vicki Giannopolous, Dr Joshua Watt, Professor Paul Haber, Professor Tim Slade, and Zachary Bryant.
Zachary Bryant is conducting the study to partially fulfil the requirements of a Doctor of Philosophy degree under the supervision of Professor Tim Slade and Associate Professor Kirsten Morley.
This study has been approved by the Ethics Review Committee (RPAH Zone) of the Sydney Local Health District. Any person with concerns or complaints about the conduct of this study should contact the Executive Officer on 02 9515 6766 and quote protocol number X22-0243.
The conduct of this study at the Royal Prince Alfred Hospital has been authorised by the Sydney Local Health District (RPAH Zone). Any person with concerns or complaints about the conduct of this study may also contact the Research Governance Officer on 02 9515 7899 and quote protocol number X22-0243.